HOME >> BIOLOGY >> NEWS
VIB presents its annual results at BIO2004 in San Francisco

San Francisco, BIO2004; The North American biotech convention 'BIO' has blossomed into the place to be. Every year, the international biotech community gathers together at this mega-happening, which this year boasts 20,000 participants. VIB (the Flanders Interuniversity Institute for Biotechnology) is coordinating the Belgian delegation to 'BIO 2004' in San Francisco, where it will present its newly published annual results. These latest results from 2003 - with the large number of major research breakthroughs, 30 patent applications, and almost 50 agreements with industry - clearly position VIB among the top in the world.

In 2003, VIB scientists achieved 180 significant breakthroughs in a variety of domains such as cancer, Alzheimer's disease, inflammatory diseases, human genetics, and plant growth. This figure surpasses that of the previous year, which was already three times as many as at the start of the institute in 1995. This result vaults Flanders' biotechnological research to the top internationally. Also in 2003, VIB expanded its research groups with 3 new ones active in emerging fields in the life sciences. In fact, this is an instance of reverse brain drain, because, after an international search, 3 Belgians proved to be the best candidates and they were eager to return to Flanders after successful careers abroad.

VIB's innovative knowledge is a continuous source of new technologies and inventions that can form the basis for new social and industrial applications, including medical diagnostics and medicines. To bring these applications into being, VIB protects its findings via patents: in 2003, 30 discoveries were sufficiently new and inventive to warrant patent applications. At the same time, VIB entered into nearly 50 collaborative agreements with business and industry. In addition, VIB was the catalyst for the creation of a new network - called 'FlandersBio' - that unites the Flemish biotech industry.


'"/>

Contact: Ann Van Gysel
inge.geysen@vib.be
32-475-336-600
VIB, Flanders Interuniversity Institute of Biotechnology
3-Jun-2004


Page: 1

Related biology news :

1. DFG presents the 2004 MAK and BAT value lists
2. Steroid-coated DNA represents new approach to gene delivery
3. ASH presents advocacy awards to Sen. Dianne Feinstein and Claude Lenfant, M.D.
4. DFG presents the new MAK and BAT Value List 2003
5. Center for Health Law and Policy presents program on bioterrorism measures and civil liberties
6. Agriculture presents common ground for rural, urban people
7. UPCI presents study on estrogenic activity of medicinal botanicals
8. UPCI presents study on dendritic cells in prostate cancer
9. UPCI presents study on discovery of protein that suppresses dendritic cells
10. USF presents new research on hyperlipidemic children
11. Biomedicines presents promising results from phase II trials of omega interferon for the treatment of hepatitis C

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/15/2017)... ivWatch LLC , a medical device company focused on improving the ... its ISO 13485 Certification, the global standard for medical device quality ... ... device for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, as it validates ...
(Date:7/20/2017)... DAL ) customers now can use fingerprints instead of their ... (DCA). ... launches biometrics to board aircraft at Reagan Washington National Airport ... Delta,s biometric boarding pass experience that launched in May at ... process to allow eligible Delta SkyMiles Members who are enrolled in CLEAR ...
(Date:6/30/2017)... ARLINGTON, Va. , June 30, 2017 /PRNewswire-USNewswire/ ... a leading developer and supplier of face and ... the ATA Featured Product provider program. ... created an innovative way to monitor a driver,s ... benefit greatly from being able to detect fatigue ...
Breaking Biology News(10 mins):
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... the stock market news outlet had provided a research update on Aytu Bioscience ... administered TRT product. , According to Soulstring, prescription rates for Natesto® have more ...
(Date:8/17/2017)... ... August 17, 2017 , ... Cynvenio Biosystems, ... today announced the launch of a new breast cancer monitoring study in partnership ... to evaluate the potential for early detection of recurrent breast cancer using LiquidBiopsy ...
(Date:8/16/2017)... ... August 16, 2017 , ... Tunnell Consulting announced ... at the ISPE Annual Meeting and Expo , to be held October 29 ... event’s theme is “Driving innovation to advance patient therapies.” , The ISPE Annual Meeting ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... the Fluidnatek® Electrospinning and Electrospraying line of nanofiber ... from table-top equipment for the lab to fully automated pilot plants and ...
Breaking Biology Technology:
Cached News: